Clinical trial

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

NCT03833206

Study summary

ClinicalTrials.gov

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention PDC-1421 Capsule Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2027-01-15

PhasePHASE1 / PHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

PDC-1421 CapsuleDRUG

Sponsors & collaborators

BioLite, Inc.lead sponsor

American BriVision Corporationcollaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03833206 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.